A serologically detected tumour-specific membrane antigen of murine lymphomas which is not the target for syngeneic graft rejection (original) (raw)

168

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davey G. C., Currie G. A., Alexander P. Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastic capacity. Br J Cancer. 1976 Jan;33(1):9–14. doi: 10.1038/bjc.1976.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Motta R. The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens. Rev Eur Etud Clin Biol. 1970 Feb;15(2):161–167. [PubMed] [Google Scholar]
  3. Parr I. Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. Br J Cancer. 1972 Jun;26(3):174–182. doi: 10.1038/bjc.1972.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Rogers M. J., Law L. W., Prat M., Oroszlan S., Appella E. Separation of the tumor rejection antigen (TSTA) from the major viral structural proteins associated with the membrance of an R-MuLV-induced leukemia. Int J Cancer. 1978 Feb 15;21(2):246–252. doi: 10.1002/ijc.2910210218. [DOI] [PubMed] [Google Scholar]
  5. Wolf A., Steele K. A., Alexander P. Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma. Br J Cancer. 1976 Feb;33(2):144–153. doi: 10.1038/bjc.1976.19. [DOI] [PMC free article] [PubMed] [Google Scholar]